http://www.biotec.no/ http://www.biotec.no/news/svein-lien-appointed-new-ceo-of-biotec-pharmacon-asa-article657-18.html Svein Lien has been appointed new CEO of Biotec Pharmacon, following Lars Viksmoen’s decision to resign after 3 years as CEO. Svein Lien will assume the position with effect from 15 March, 2010. Wed, 10 Mar 2010 14:33:03 +0100 http://www.biotec.no/news/biotec-pharmacon-presenting-re-established-platform-at-bio-europe-2010-article656-18.html Dr Sven Rohmann presented on behalf of Biotec Pharmacon at BIO-Europe Spring 2010 in Barcelona. The presentation took place at March 9, 12:30, under the AutoImmune/Inflammation Section. Tue, 09 Mar 2010 09:28:33 +0100 http://www.biotec.no/news/testing-sbg-packaging-containers-after-weak-results-from-oral-mucositis-study-article651-18.html Biotec Pharmacon has received data showing that SBG failed to show superiority over placebo in the phase III study for oral mucositis. Newly available biological activity assays indicate that SBG used in the diabetic ulcer program may have been inactivated as a result of interaction with polyethylene in the product containers. The company plans to carry out accelerated stability studies of SBG with alternative containers. Mon, 22 Feb 2010 08:26:20 +0100 http://www.biotec.no/news/biotec-pharmacon-to-focus-on-bio-pharmaceuticals-sells-immunocorp-consumer-health-as-article650-18.html Biotec Pharmacon ASA has reached an agreement on the sale of its wholly-owned subsidiaries Immunocorp Consumer Health AS and Immunocorp Inc. USA to the Norwegian company Sana Pharma AS for NOK 31.5 million. Wed, 30 Dec 2009 14:33:10 +0100 http://www.biotec.no/news/extraordinary-general-meeting-article649-18.html The shareholders have been summoned by the Board to an extraordinary general meeting to be held January 21st, 2010. Wed, 30 Dec 2009 10:13:59 +0100